| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues [+] | 30.2 | 15.1 | 4.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Royalties | | | | | | | | 2.8 |
| Products | 30.0 | 15.0 | 4.1 | | | | 0.0 | 0.0 |
| Revenue growth | 99.2% | 266.5% | | | | -100.0% | 101.1% | |
| Cost of goods sold [+] | 19.2 | 16.1 | 3.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Direct costs | 6.6 | 6.6 | | | | | | |
| Gross profit | 11.0 | -0.9 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 36.4% | -6.1% | 4.7% | | | | 86.9% | 68.5% |
| Selling, general and administrative [+] | 38.5 | 27.5 | 30.4 | 18.0 | 3.2 | 4.8 | 3.1 | 3.8 |
| Sales and marketing | 14.7 | 7.8 | 3.1 | | | | | |
| General and administrative | 23.8 | 19.7 | 27.3 | 18.0 | 3.2 | 4.8 | 3.1 | 3.8 |
| Research and development | 14.4 | 11.5 | 9.3 | 8.5 | 7.6 | 4.6 | 4.1 | 2.8 |
| Other operating expenses | -6.6 | -6.6 | | | 0.0 | 0.1 | 0.0 | 0.0 |
| EBITDA [+] | -34.8 | -32.8 | -37.4 | -24.8 | -10.7 | -9.4 | -7.1 | -6.4 |
| EBITDA growth | 6.3% | -12.5% | 50.7% | 133.1% | 13.2% | 33.4% | 9.5% | 12.7% |
| EBITDA margin | -115.4% | -216.3% | -906.1% | | | | -14789.8% | -27166.7% |
| Depreciation | -0.9 | -0.7 | 0.6 | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 |
| EBITA | -33.9 | -32.0 | -38.0 | -25.2 | -10.8 | -9.5 | -7.1 | -6.5 |
| EBITA margin | -112.5% | -211.5% | -920.7% | | | | -14933.1% | -27369.7% |
| Amortization of intangibles | 1.3 | 1.3 | 1.6 | 1.3 | | | | |
| EBIT [+] | -35.3 | -33.3 | -39.6 | -26.5 | -10.8 | -9.5 | -7.1 | -6.5 |
| EBIT growth | 5.9% | -15.8% | 49.3% | 146.1% | 13.6% | 33.0% | 9.7% | 13.2% |
| EBIT margin | -117.0% | -220.0% | -958.2% | | | | -14933.1% | -27369.7% |
| Non-recurring items [+] | 6.6 | 18.2 | 7.4 | 0.7 | | | | 19.7 |
| Asset impairment | | 1.5 | | | | | | |
| Loss (gain) on sale of assets | | -1.2 | 0.4 | | | | | |
| In-process research & development | 6.6 | 17.8 | 7.0 | 0.7 | | | | 19.7 |
| Interest income, net [+] | 0.3 | 0.9 | 1.1 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 |
| Interest expense | 0.0 | 0.0 | | 0.0 | 0.0 | | 0.1 | 0.0 |
| Interest income | 0.3 | 0.9 | 1.1 | 0.0 | 0.0 | 0.0 | | |
| Other income (expense), net [+] | 5.7 | 3.2 | 0.5 | -0.3 | 0.0 | | | |
| Gain (loss) on foreign currency transactions | 0.3 | -1.3 | 0.8 | | | | | |
| Other non-operating income | | | 0.0 | | | | | |
| Other | 0.6 | 0.1 | 0.0 | | | | | |
| Pre-tax income | -35.8 | -47.5 | -45.4 | -27.5 | -10.8 | -9.5 | -7.2 | -26.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -35.8 | -47.5 | -45.4 | -27.5 | -10.8 | -9.5 | -7.2 | -26.2 |
| Net margin | -118.8% | -313.8% | -1098.1% | | | | -15104.0% | -110432.5% |
| |
| Basic EPS [+] | ($0.26) | ($0.43) | ($0.47) | ($0.32) | ($0.18) | ($0.17) | ($0.22) | ($0.92) |
| Growth | -38.8% | -9.0% | 45.9% | 85.1% | 3.5% | -23.8% | -75.8% | 317.2% |
| Diluted EPS [+] | ($0.26) | ($0.43) | ($0.47) | ($0.32) | ($0.18) | ($0.17) | ($0.22) | ($0.92) |
| Growth | -38.8% | -9.0% | 45.9% | 85.1% | 3.5% | -23.8% | -75.8% | 317.2% |
| |
| Shares outstanding (basic) [+] | 136.1 | 110.5 | 95.9 | 84.8 | 61.5 | 55.9 | 32.4 | 28.6 |
| Growth | 23.2% | 15.1% | 13.2% | 37.8% | 10.1% | 72.2% | 13.5% | 9.5% |
| Shares outstanding (diluted) [+] | 136.1 | 110.5 | 95.9 | 84.8 | 61.5 | 55.9 | 32.4 | 28.6 |
| Growth | 23.2% | 15.1% | 13.2% | 37.8% | 10.1% | 72.2% | 13.5% | 9.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |